ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 68 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q4 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,161 | +99.4% | 4,053 | +136.5% | 0.00% | – |
| Q2 2023 | $1,585 | +29.9% | 1,714 | +53.2% | 0.00% | – |
| Q1 2023 | $1,220 | -10.8% | 1,119 | +19.4% | 0.00% | – |
| Q4 2022 | $1,368 | -99.7% | 937 | +122.0% | 0.00% | – |
| Q3 2022 | $454,000 | -87.2% | 422 | -79.8% | 0.00% | – |
| Q2 2022 | $3,556,000 | -79.0% | 2,092 | -46.9% | 0.00% | – |
| Q1 2019 | $16,929,000 | -25.2% | 3,937 | 0.0% | 0.00% | – |
| Q4 2018 | $22,638,000 | -83.8% | 3,937 | -61.8% | 0.00% | – |
| Q3 2018 | $139,695,000 | +14.2% | 10,302 | 0.0% | 0.00% | – |
| Q2 2018 | $122,285,000 | – | 10,302 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syncona Portfolio Ltd | 1,377,294 | $2,341,000 | 3.33% |
| Matrix Capital Management Company, LP | 38,974,185 | $66,256,000 | 1.50% |
| NEA Management Company, LLC | 17,082,612 | $29,040,000 | 1.49% |
| Endurant Capital Management LP | 1,824,065 | $3,101,000 | 1.09% |
| Long Focus Capital Management, LLC | 4,679,491 | $7,955,000 | 0.83% |
| Key Client Fiduciary Advisors, LLC | 416,166 | $707,000 | 0.69% |
| PFM Health Sciences, LP | 9,109,780 | $15,487,000 | 0.59% |
| ACT CAPITAL MANAGEMENT, LLC | 90,000 | $153,000 | 0.21% |
| DAFNA Capital Management LLC | 351,064 | $597,000 | 0.16% |
| Rock Springs Capital Management LP | 2,357,544 | $4,008,000 | 0.12% |